Jung, Y. S., Han, M., Park, S., & Cheon, J. H. (2021). Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease. Gut Liver.
Chicago-стиль цитированияJung, Yoon Suk, Minkyung Han, Sohee Park, and Jae Hee Cheon. "Comparison of Long-term Outcomes of Infliximab Versus Adalimumab in 1,488 Biologic-Naive Korean Patients With Crohn’s Disease." Gut Liver 2021.
MLA-цитированиеJung, Yoon Suk, Minkyung Han, Sohee Park, and Jae Hee Cheon. "Comparison of Long-term Outcomes of Infliximab Versus Adalimumab in 1,488 Biologic-Naive Korean Patients With Crohn’s Disease." Gut Liver 2021.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.